|
Alfred G. Gilman M.D. Ph.D. executive vice president for academic affairs and provost at the University of Texas Southwestern Medical Center at Dallas; dean of Southwestern Medical School; and regental professor of pharmacology the University of Texas Southwestern medical Center was elected to the board of directors of Eli Lilly and Company in 1995. He also holds the Raymond and Ellen Willie Distinguished Chair of Molecular Neuropharmacology The Nadine and Tom Craddick Distinguished Chair in Medical Science and the Atticus James Gill M.D. Chair in Medical Science at the University.
Born in New Haven Connecticut he received a bachelor of science degree summa cum laude in biochemistry in 1962 from Yale University and his doctor of medicine degree and doctorate in pharmacology in 1969 from Case Western Reserve University. He received further training as a pharmacology research associate in the Laboratory of Biochemical Genetics at the National Institutes of Health beginning in 1969. In 1971 he began a ten-year stay at the University of Virginia in Charlottesville where his positions included assistant associate and professor of pharmacology and director of the medical scientist training program.
He is a member of the board of directors of Regeneron Pharmaceuticals Inc. He was the editor of Goodman and Gilman's The Pharmacological Basis of Therapeutics from 1980,1990.
Gilman has been the recipient of many awards including among others The Nobel Prize in Physiology or Medicine (1994); American Heart Association Basic Science Research Prize (1990); American Cancer Society Medal of Honor (1995); Albert Lasker Basic Medical Research Award (1989); election to the National Academy of Sciences (1985); and The Gairdner Foundation International Award (1984). He has received honorary degrees from the University of Chicago (1990) Case Western Reserve University (1995) Yale University (1997) and the University of Miami (1999). | 